E Fund Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Sell |
14,035
-4,683
| -25% | -$101K | 0.01% | 300 |
|
|
2025
Q1 | $311K | Buy |
18,718
+8,090
| +76% | +$134K | 0.01% | 304 |
|
|
2024
Q4 | $195K | Sell |
10,628
-7,704
| -42% | -$141K | 0.01% | 368 |
|
|
2024
Q3 | $282K | Sell |
18,332
-196
| -1% | -$3.01K | 0.01% | 269 |
|
|
2024
Q2 | $301K | Buy |
18,528
+40
| +0.2% | +$650 | 0.02% | 231 |
|
|
2024
Q1 | $342K | Sell |
18,488
-4,405
| -19% | -$81.4K | 0.02% | 257 |
|
|
2023
Q4 | $717K | Buy |
22,893
+5,605
| +32% | +$175K | 0.05% | 110 |
|
|
2023
Q3 | $360K | Sell |
17,288
-780
| -4% | -$16.2K | 0.03% | 183 |
|
|
2023
Q2 | $433K | Sell |
18,068
-799
| -4% | -$19.1K | 0.03% | 144 |
|
|
2023
Q1 | $355K | Sell |
18,867
-10,303
| -35% | -$194K | 0.03% | 202 |
|
|
2022
Q4 | $464K | Buy |
29,170
+1,763
| +6% | +$28K | 0.04% | 142 |
|
|
2022
Q3 | $448K | Buy |
27,407
+1,786
| +7% | +$29.2K | 0.04% | 145 |
|
|
2022
Q2 | $361K | Buy |
25,621
+14,048
| +121% | +$198K | 0.03% | 205 |
|
|
2022
Q1 | $280K | Buy |
+11,573
| New | +$280K | 0.01% | 221 |
|
|
2021
Q4 | – | Sell |
-10,673
| Closed | -$177K | – | 302 |
|
|
2021
Q3 | $177K | Buy |
+10,673
| New | +$177K | 0.01% | 237 |
|